Clinical Trial Update: Caspofungin to Prevent Candidiasis in Adults in Hospital Intensive Care Units [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating caspofungin to prevent candidiasis in adults in hospital ICU settings has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis

Drugs mentioned

• Caspofungin (Cancidas) (caspofungin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Candidiasis | Phase 3 | Status: COMPLETED